A former Mylan executive has pleaded guilty to an insider trading scheme that netted him $4.27 million. After leaving the company in 2017, Dayakar Mallu …
Journal For Clinical Studies has a distinguished editorial advisory board providing the best guidelines for global clinical trials. Your resource for Multisite Studies and emerging markets.
